JP Stock MarketDetailed Quotes

4888 Stella Pharma

Watchlist

501
+6+1.21%

20min DelayMarket Closed Nov 29 15:30 JST

17.05BMarket Cap-20316P/E (Static)

Stella Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

Total revenue

17.65%269.49M

28.57%69.3M

-44.19%46.2M

92.4M

61.6M

229.07M

53.9M

82.77M

Cost of revenue

135.92%52.19M

133.44%14.68M

-30.35%6.59M

23.63M

7.29M

22.12M

6.29M

9.46M

Gross profit

5.00%217.3M

14.72%54.62M

-45.97%39.61M

68.76M

54.31M

206.94M

47.61M

73.31M

Operating expense

-3.56%977.6M

-0.98%347.95M

-2.11%205.35M

206.94M

217.37M

1.01B

351.38M

209.77M

Operating profit

5.76%-760.3M

3.44%-293.33M

-21.46%-165.74M

-138.17M

-163.06M

-806.78M

-303.77M

-136.46M

Net non-operating interest income (expenses)

62.62%-3.09M

95.62%-258K

85.01%-257K

-1.4M

-1.18M

-8.28M

-5.89M

-1.71M

Non-operating interest income

0.91%1.44M

0.86%352K

2.25%363K

--357K

--367K

--1.43M

--349K

--355K

Non-operating interest expense

-19.22%2.08M

-12.76%506K

-15.11%517K

--506K

--555K

--2.58M

--580K

--609K

Total other finance cost

-65.62%2.45M

-98.16%104K

--103K

--1.25M

--987K

--7.12M

--5.66M

----

Net investment income

-1K

74K

-2K

-34K

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-768K

-18K

-750K

Less:Other special charges

--768K

--0

--18K

--0

--750K

----

Other non-operating income (expenses)

-91.86%3.18M

-99.25%106K

100,500.00%3.02M

58K

39.11M

14.19M

Income before tax

1.93%-760.98M

0.65%-293.55M

-17.97%-162.99M

-139.44M

-164.99M

-775.97M

-295.48M

-138.17M

Income tax

-2.74%2.77M

395.31%634K

-21.39%713K

713K

712K

2.85M

128K

907K

Net income

1.94%-763.75M

0.48%-294.19M

-17.71%-163.71M

-140.16M

-165.7M

-778.82M

-295.6M

-139.08M

Net income continuous operations

1.94%-763.75M

0.48%-294.19M

-17.71%-163.71M

---140.16M

---165.7M

---778.82M

---295.6M

---139.08M

Noncontrolling interests

Net income attributable to the company

1.94%-763.75M

0.48%-294.19M

-17.71%-163.71M

-140.16M

-165.7M

-778.82M

-295.6M

-139.08M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

1.94%-763.75M

0.48%-294.19M

-17.71%-163.71M

-140.16M

-165.7M

-778.82M

-295.6M

-139.08M

Gross dividend payment

Basic earnings per share

8.57%-24.66

6.42%-9.47

-8.04%-5.24

-4.51

-5.44

-26.97

-10.12

-4.85

Diluted earnings per share

8.57%-24.66

6.42%-9.47

-8.10%-5.2427

-4.51

-5.44

-26.97

-10.12

-4.85

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022
Total revenue	17.65%269.49M	28.57%69.3M	-44.19%46.2M	92.4M	61.6M	229.07M	53.9M	82.77M
Cost of revenue	135.92%52.19M	133.44%14.68M	-30.35%6.59M	23.63M	7.29M	22.12M	6.29M	9.46M
Gross profit	5.00%217.3M	14.72%54.62M	-45.97%39.61M	68.76M	54.31M	206.94M	47.61M	73.31M
Operating expense	-3.56%977.6M	-0.98%347.95M	-2.11%205.35M	206.94M	217.37M	1.01B	351.38M	209.77M
Operating profit	5.76%-760.3M	3.44%-293.33M	-21.46%-165.74M	-138.17M	-163.06M	-806.78M	-303.77M	-136.46M
Net non-operating interest income (expenses)	62.62%-3.09M	95.62%-258K	85.01%-257K	-1.4M	-1.18M	-8.28M	-5.89M	-1.71M
Non-operating interest income	0.91%1.44M	0.86%352K	2.25%363K	--357K	--367K	--1.43M	--349K	--355K
Non-operating interest expense	-19.22%2.08M	-12.76%506K	-15.11%517K	--506K	--555K	--2.58M	--580K	--609K
Total other finance cost	-65.62%2.45M	-98.16%104K	--103K	--1.25M	--987K	--7.12M	--5.66M	----
Net investment income			-1K	74K	-2K	-34K	0	0
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	-768K	0	-18K	0	-750K	0	0	0
Less:Other special charges	--768K	--0	--18K	--0	--750K	----	----	----
Other non-operating income (expenses)	-91.86%3.18M	-99.25%106K	100,500.00%3.02M	58K	2K	39.11M	14.19M	3K
Income before tax	1.93%-760.98M	0.65%-293.55M	-17.97%-162.99M	-139.44M	-164.99M	-775.97M	-295.48M	-138.17M
Income tax	-2.74%2.77M	395.31%634K	-21.39%713K	713K	712K	2.85M	128K	907K
Net income	1.94%-763.75M	0.48%-294.19M	-17.71%-163.71M	-140.16M	-165.7M	-778.82M	-295.6M	-139.08M
Net income continuous operations	1.94%-763.75M	0.48%-294.19M	-17.71%-163.71M	---140.16M	---165.7M	---778.82M	---295.6M	---139.08M
Noncontrolling interests
Net income attributable to the company	1.94%-763.75M	0.48%-294.19M	-17.71%-163.71M	-140.16M	-165.7M	-778.82M	-295.6M	-139.08M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	1.94%-763.75M	0.48%-294.19M	-17.71%-163.71M	-140.16M	-165.7M	-778.82M	-295.6M	-139.08M
Gross dividend payment
Basic earnings per share	8.57%-24.66	6.42%-9.47	-8.04%-5.24	-4.51	-5.44	-26.97	-10.12	-4.85
Diluted earnings per share	8.57%-24.66	6.42%-9.47	-8.10%-5.2427	-4.51	-5.44	-26.97	-10.12	-4.85
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data